Over the last 7 days, the Life Sciences industry has dropped 1.4%, driven by LigaChem Biosciences declining 1.9%. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 16% per annum.
Has the South Korean Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 17 May 2024 | ₩61.6t | ₩4.4t | ₩637.0b | 19.8x | 96.6x | 14.1x |
Sun, 14 Apr 2024 | ₩62.7t | ₩4.7t | ₩654.7b | 18.9x | 95.7x | 13.4x |
Tue, 12 Mar 2024 | ₩65.7t | ₩4.6t | ₩635.2b | 34.6x | 103.5x | 14.2x |
Thu, 08 Feb 2024 | ₩64.2t | ₩4.5t | ₩714.4b | 33.9x | 89.9x | 14.2x |
Sat, 06 Jan 2024 | ₩60.1t | ₩4.5t | ₩721.5b | 32.6x | 83.4x | 13.2x |
Mon, 04 Dec 2023 | ₩56.3t | ₩4.5t | ₩721.6b | 31.7x | 78x | 12.4x |
Wed, 01 Nov 2023 | ₩55.4t | ₩4.4t | ₩660.9b | 21.5x | 83.9x | 12.6x |
Fri, 29 Sep 2023 | ₩54.3t | ₩4.4t | ₩660.9b | 30.3x | 82.1x | 12.3x |
Sun, 27 Aug 2023 | ₩59.8t | ₩4.4t | ₩693.2b | 28.9x | 86.3x | 13.6x |
Tue, 25 Jul 2023 | ₩58.1t | ₩4.2t | ₩673.4b | 28.5x | 86.3x | 13.9x |
Thu, 22 Jun 2023 | ₩58.9t | ₩4.2t | ₩666.5b | 29.5x | 88.4x | 13.9x |
Sat, 20 May 2023 | ₩61.0t | ₩4.1t | ₩626.3b | 27.3x | 97.4x | 14.9x |
Mon, 17 Apr 2023 | ₩64.0t | ₩4.1t | ₩626.3b | 30.5x | 102.3x | 15.7x |
Wed, 15 Mar 2023 | ₩60.1t | ₩4.0t | ₩715.4b | 25.7x | 84x | 15x |
Fri, 10 Feb 2023 | ₩63.6t | ₩3.5t | ₩427.8b | 21.2x | 148.7x | 18.3x |
Sun, 08 Jan 2023 | ₩63.0t | ₩3.4t | ₩428.7b | 21.1x | 147.1x | 18.3x |
Tue, 06 Dec 2022 | ₩64.8t | ₩3.4t | ₩428.7b | 19.1x | 151.2x | 18.9x |
Thu, 03 Nov 2022 | ₩67.4t | ₩3.0t | ₩448.5b | 23.6x | 150.2x | 22.6x |
Sat, 01 Oct 2022 | ₩62.8t | ₩3.0t | ₩448.5b | 21.9x | 140x | 21x |
Mon, 29 Aug 2022 | ₩66.7t | ₩2.9t | ₩476.6b | 26.4x | 140x | 22.7x |
Wed, 27 Jul 2022 | ₩65.5t | ₩2.7t | ₩454.7b | 29.1x | 144x | 24.1x |
Fri, 24 Jun 2022 | ₩64.2t | ₩2.7t | ₩454.7b | 26.3x | 141.3x | 23.7x |
Sun, 22 May 2022 | ₩64.2t | ₩2.4t | ₩381.8b | 21.7x | 168.1x | 26.5x |
Tue, 19 Apr 2022 | ₩61.6t | ₩2.4t | ₩379.4b | 24.6x | 162.3x | 25.4x |
Thu, 17 Mar 2022 | ₩61.3t | ₩2.4t | ₩392.9b | 26.7x | 156.1x | 25.3x |
Sat, 12 Feb 2022 | ₩56.4t | ₩2.3t | ₩412.7b | 25.4x | 136.6x | 24x |
Mon, 10 Jan 2022 | ₩63.6t | ₩2.3t | ₩412.7b | 27.8x | 154x | 27.1x |
Wed, 08 Dec 2021 | ₩67.3t | ₩2.3t | ₩412.7b | 27.7x | 163x | 28.6x |
Fri, 05 Nov 2021 | ₩64.4t | ₩2.1t | ₩329.9b | 26.9x | 195.1x | 30x |
Sun, 03 Oct 2021 | ₩65.1t | ₩2.1t | ₩329.9b | 27x | 197.4x | 30.3x |
Tue, 31 Aug 2021 | ₩71.8t | ₩2.2t | ₩336.8b | 35.6x | 213.2x | 32.5x |
Wed, 07 Jul 2021 | ₩64.5t | ₩2.2t | ₩336.8b | 37.9x | 191.6x | 29.2x |
259.8x
Which industries have driven the changes within the South Korean Healthcare industry?
KR Market | 1.15% | |
Healthcare | 0.014% | |
Life Sciences | 0.22% | |
Clinical Research and Equipment | 0.22% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A207940 Samsung BiologicsLtd | ₩784.00k | 0.4% +₩213.5b | 0.5% | PE65.1x | |
A220100 FutureChemLtd | ₩13.52k | 12.4% +₩32.9b | 73.1% | PS21.4x | |
A038290 Macrogen | ₩22.10k | 6.5% +₩13.5b | 12.8% | PS1.7x | |
A039860 NanoEntek | ₩3.73k | 11.9% +₩10.6b | -26.7% | PS3.7x | |
A383930 DT&CRO | ₩9.05k | 7.7% +₩8.3b | 56.6% | n/a |